Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Response from PTSC IR on Shareholders meeting

Perhaps they are waiting for the CEO/CFO to crack open his wallet and actually spend $140 for a thousand shares of the company he oversees. His lack of ownership ranks high among the most ludicrous things about PTSC. Almost unbelievable; then again, look at who he reports to.

Share
New Message
Please login to post a reply